معرفی
Jean Lefebvre is a Full Professor in the Department of Pharmacy at the Faculty of Pharmacy, Université Laval, Quebec, Canada. He holds a Ph.D. in Pharmacy from Laval University and completed a Fellowship in Clinical Pharmacology at Vanderbilt University, USA. He is actively engaged in research, teaching, and professional leadership in pharmacy and cardiovascular pharmacology.
Education:
- Bachelor of Pharmacy (B Pharm), Université Laval
- Master's in Hospital Pharmacy (M Sc), Université Laval
- Doctorate in Pharmacy (Ph D), Laval University (supervised by Dr. Jacques Turgeon)
- Fellowship in Clinical Pharmacology, Vanderbilt University, USA (under Dr. Nancy J. Brown)
His research focuses on cardiovascular pharmacotherapy, particularly arterial hypertension, pharmacogenomics (e.g., CYP2D6 and nebivolol response), and clinical trial methodology. He investigates optimal antihypertensive strategies, including dose escalation and combination therapies. His work bridges clinical practice and pharmacological science, aiming to improve patient outcomes through evidence-based interventions.
An analysis of his recent publications reveals a strong trend in hypertension management, pharmacogenomics, and clinical pharmacology, with methodological rigor in trial design and drug evaluation. He also contributes to interdisciplinary research in nutrition and cardiology, exploring how medications complement lifestyle interventions.
Scientific and Professional Affiliations:
- Vice-President, International Conference of Deans of French-Speaking Faculties of Pharmacy (CIDPharmEF)
- Treasurer, Association of Faculties of Pharmacy of Canada (AFPC)
- Member, Order of Pharmacists of Quebec (OPQ)
- Member, Association of Pharmacists in Healthcare Establishments (APES)
- Member, Council of Physicians, Dentists and Pharmacists, CHU de Québec
- Member, CHU de Québec Research Center
Jean Lefebvre supervises graduate students in the Master's Program in Advanced Pharmacotherapy and leads workshops in biostatistics and critical literature analysis. He is involved in continuing education through programs like the Virtual Pharmacy Intervention Program (PIVEP) and the professional doctorate pathway for licensed pharmacists. He teaches in both undergraduate (cardiovascular pharmaceutical care) and graduate curricula.
He leads research initiatives in clinical trials on hypertension, pharmacogenomics of arterial hypertension, and cardiovascular pharmacotherapy, contributing to national and international guidelines through his scholarly work and professional engagement.
